Understanding early diagnosis and mechanisms of type 1 diabetes through single cell analysis
Early diagnosis and mechanistic studies of type 1 diabetes using single cell analysis
This study is looking at tiny cells in the body to find out how type 1 diabetes starts, and if you join in by sharing your samples, it could help create better ways to diagnose and treat the condition.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Scripps Research Institute, the NIH-funded |
| Lab location | 1 site (La Jolla, United States) |
| Project ID | NIH-11123536 on NIH RePORTER |
What this research studies
This research focuses on the early diagnosis of type 1 diabetes by examining individual cells to understand the disease's mechanisms. By utilizing advanced single cell analysis techniques, the study aims to identify specific biological markers and immune responses involved in the onset of type 1 diabetes. Patients may have the opportunity to contribute samples and data, which could lead to more accurate diagnostic tools and targeted therapies. The research seeks to unravel the complexities of autoimmune responses that lead to diabetes, potentially improving patient outcomes.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals at risk for type 1 diabetes, particularly children and young adults showing early signs of the disease.
Not a fit: Patients with established type 1 diabetes or those who do not exhibit any risk factors for the disease may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to earlier and more accurate diagnoses of type 1 diabetes, improving treatment options for patients.
How similar studies have performed: Previous research using single cell analysis has shown promise in understanding autoimmune diseases, indicating that this approach could yield valuable insights.
Where this research is happening
La Jolla, United States
- Scripps Research Institute, the — La Jolla, United States (Active)
Researchers
- Principal investigator: Teyton, Luc — Scripps Research Institute, the
- Study coordinator: Teyton, Luc
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.